Cargando…

Possibility of selection against mtDNA mutations in tumors

Several studies of tumors have revealed substantial numbers of clonally expanded somatic mutations in mitochondrial DNA (mtDNA), not observed in adjacent intact tissues. These findings were interpreted as indicating the involvement of mtDNA mutations in tumorigenesis. Such comparisons, however, igno...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaidakov, M, Reis, RJ Shmookler
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1232865/
https://www.ncbi.nlm.nih.gov/pubmed/16159390
http://dx.doi.org/10.1186/1476-4598-4-36
_version_ 1782124992550404096
author Khaidakov, M
Reis, RJ Shmookler
author_facet Khaidakov, M
Reis, RJ Shmookler
author_sort Khaidakov, M
collection PubMed
description Several studies of tumors have revealed substantial numbers of clonally expanded somatic mutations in mitochondrial DNA (mtDNA), not observed in adjacent intact tissues. These findings were interpreted as indicating the involvement of mtDNA mutations in tumorigenesis. Such comparisons, however, ignore an important confounding factor: the monoclonal origin of tumors as opposed to the highly polyclonal nature of normal tissues. Analysis of recently published data on the incidence of somatic mutations in nontumor monoclonal cells suggests that, contrary to the prevailing view, the process of tumorigenesis may be accompanied by active selection against detrimental mtDNA mutations.
format Text
id pubmed-1232865
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-12328652005-09-24 Possibility of selection against mtDNA mutations in tumors Khaidakov, M Reis, RJ Shmookler Mol Cancer Review Several studies of tumors have revealed substantial numbers of clonally expanded somatic mutations in mitochondrial DNA (mtDNA), not observed in adjacent intact tissues. These findings were interpreted as indicating the involvement of mtDNA mutations in tumorigenesis. Such comparisons, however, ignore an important confounding factor: the monoclonal origin of tumors as opposed to the highly polyclonal nature of normal tissues. Analysis of recently published data on the incidence of somatic mutations in nontumor monoclonal cells suggests that, contrary to the prevailing view, the process of tumorigenesis may be accompanied by active selection against detrimental mtDNA mutations. BioMed Central 2005-09-13 /pmc/articles/PMC1232865/ /pubmed/16159390 http://dx.doi.org/10.1186/1476-4598-4-36 Text en Copyright © 2005 Khaidakov and Reis; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Khaidakov, M
Reis, RJ Shmookler
Possibility of selection against mtDNA mutations in tumors
title Possibility of selection against mtDNA mutations in tumors
title_full Possibility of selection against mtDNA mutations in tumors
title_fullStr Possibility of selection against mtDNA mutations in tumors
title_full_unstemmed Possibility of selection against mtDNA mutations in tumors
title_short Possibility of selection against mtDNA mutations in tumors
title_sort possibility of selection against mtdna mutations in tumors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1232865/
https://www.ncbi.nlm.nih.gov/pubmed/16159390
http://dx.doi.org/10.1186/1476-4598-4-36
work_keys_str_mv AT khaidakovm possibilityofselectionagainstmtdnamutationsintumors
AT reisrjshmookler possibilityofselectionagainstmtdnamutationsintumors